Oppenheimer analyst Jay Olson joins BiotechTV for Analyst Thursdays and talks obesity and earnings
Jay Olson shares learnings from a physician survey Oppenheimer conducted on obesity, and comments on Viking, Amgen, Madrigal, Acadia, Bicycle, Incyte, Jasper, and Q32 Bio.